The high tech component industry faces similar challenges of marketing their products around the world from a relatively few world scale production facilities. In our view, their operating models can be usefully studied and adapted to meet the strategic needs of the global pharmaceutical companies.
The research & development based pharmaceutical sector is grappling with a series of landscape-shifting pressures. By SI Associates
NGP gathers some of the industry's leading experts to discuss the importance of Lean and Six Sigma in pharmaceutical manufacturing. With ESP, SherTrack and 3P Partners, a DL Shumar & Associates Company
Carmen Doran of Novartis Pharma Technical Operations explains how the unique combination of Lean and Six Sigma is bringing about significant performance improvements through the work of the company's global and local IQP Champions.
Domingo Traver of Novartis Pharma Technical Operations talks about the satisfaction he derives from the successful implementation of Lean and Six Sigma in the pharmaceutical supply chain.